Navigation Links
Pharmacyclics' Novel Factor VIIa Inhibitor Demonstrates Potential Inhibition of Tumor Growth in Multiple Types of Cancer
Date:4/16/2008

s well as angiogenesis, or the growth of new blood vessels that supply the tumors with nutrients and oxygen. Activation of Factor VII (Factor VIIa) by tissue factor also leads to the high incidence of thrombotic complications seen in cancer patients. PCI-27483 selectively inhibits Factor VIIa when it is complexed with tissue factor.

"We're encouraged by the promising preclinical results with PCI-27483 as we broaden our portfolio of product opportunities," said Richard A. Miller, M.D., president and chief executive officer of Pharmacyclics. "We are working to move additional drug candidates forward from our diverse pipeline, including an HDAC inhibitor, now in a Phase 1 clinical trial for solid tumors, and motexafin gadolinium, which is currently in two Phase 2 trials sponsored by the National Cancer Institute."

About Pharmacyclics

Pharmacyclics is a pharmaceutical company developing innovative products to treat cancer and other serious diseases. The company is leveraging its small-molecule drug development expertise to build a pipeline in oncology and other diseases based on a wide range of targets, pathways and mechanisms. More information about the company, its technology, and products can be found at http://www.pharmacyclics.com. Pharmacyclics(R) and the "pentadentate" logo(R) are registered trademarks of Pharmacyclics, Inc.

NOTE: Other than statements of historical fact, the statements made in this press release about plans for filing an IND for PCI-27483, and other future plans for our clinical trials, progress of and reports of results from preclinical and clinical studies, clinical development plans and product development and corporate partnering activities are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. The words "project," "believe," "will," "may," "continue," "plan," "expect," "intend," "anticipate," variations of such w
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
2. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
3. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
4. Genmab A/S - Company Announcement: Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS
5. FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment
6. BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer
7. Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting
8. Parion Sciences Announces Phase I Clinical Results for Novel Dry Mouth Treatment
9. NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society
10. Sangart Completes Enrollment in Phase III Study of Its Novel Blood Substitute Hemospan
11. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 As health officials across ... virus, select Meijer pharmacies in Michigan ... to eligible patients, enabling Meijer pharmacists to administer tests and, ... set by a physician participating in the study. ...
(Date:1/15/2014)... Corporation (the "Company") (NASDAQ: CLSN ) today ... to purchase an aggregate of approximately $15 million of ... offering, led by a dedicated health care fund. ... these investors pursuant to which the Company agreed to ...
(Date:1/15/2014)... , Jan. 15, 2014  Humberto C. Antunes,  Galderma  ... Award" from the Journal of Drugs in Dermatology ... Clinical Conference (ODAC). The event is January 17-20, 2014, at the ... . The ODAC is a ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... FHC ) today announced that it has received ... Brazilian Ministry of Health. It is anticipated,that shipments will ... by UNAIDS and other global public agencies for its,highly ... pleased that Brazilian women will continue to have access ...
... 78% to 100% with ... Masimo,s PI measurement, IRVINE, Calif., ... Read-Through Motion and Low,Perfusion pulse oximetry, reported that a new independent ... (PI),to improve detection of congenital heart defects (CHD) in newborns with,duct-dependent ...
Cached Medicine Technology:Female Health Company Receives Brazilian Order: Four Million FC Female Condoms 2New Research Shows Masimo Perfusion Index (PI) Effective in the Noninvasive Detection of Congenital Heart Defects (CHD) in Newborns 2New Research Shows Masimo Perfusion Index (PI) Effective in the Noninvasive Detection of Congenital Heart Defects (CHD) in Newborns 3New Research Shows Masimo Perfusion Index (PI) Effective in the Noninvasive Detection of Congenital Heart Defects (CHD) in Newborns 4
(Date:7/11/2014)... that an "expressive therapy" group intervention conducted by ... disclose their health status and improves their social ... their relationships., "Medication alone is totally insufficient," said ... director of the Women,s HIV Program at UCSF. ... effective antiretroviral therapy but far too many are ...
(Date:7/11/2014)... Recently, iFitDress.com, a leading online supplier of wedding ... new collection of evening dresses for 2014. ... all these beautiful items are provided with big discounts, ... offer is July 22. , According to the ... to customer satisfaction. On the company’s website, sincere customer ...
(Date:7/11/2014)... Organic Crop Farming in Australia ... limelight over the past decade. According to IBISWorld industry ... be an alternative food eaten only by minority groups, ... food.” Organic crop farmers have reaped the benefits of ... herbs over the past five years. Industry revenue is ...
(Date:7/11/2014)... patients, the era of personalized medicine may be just ... Stem Cell researcher Min Yu and scientists at Massachusetts ... July 11 study in Science , Yu and ... circulating through the blood streams of six patients. Some ... metastasis, which travel to and establish secondary tumors in ...
(Date:7/11/2014)... Alliance Labs announced that they will be ... Begley Jr, airing later this year 2014, via Discovery ... episode, Innovations will explore DocuSol® Kids, a mini-enema containing ... glycol base designed to give adolescents general constipation relief. ... a hyperosmotic laxative by drawing water into the bowel ...
Breaking Medicine News(10 mins):Health News:'Expressive therapy" intervention assists women living with HIV 2Health News:Worldwide Chic Ladies Can Buy Cheap Evening Dresses at iFitDress.com 2Health News:Organic Crop Farming in Australia Industry Market Research Report Now Available from IBISWorld 2Health News:Organic Crop Farming in Australia Industry Market Research Report Now Available from IBISWorld 3Health News:Organic Crop Farming in Australia Industry Market Research Report Now Available from IBISWorld 4Health News:Alliance Labs & DocuSol® to be Featured in Upcoming Episode of Innovations 2
... asked to investigate Australia’s crippled mental health services and ... that the funding would triple for Australia's mental health ... set up if the Government accepts the demands of ... release mental health patients from institutions into the community. ...
... long waiting lists. He said that they can take their health ... He guaranteed that one can open the door to legal action ... , By this the framework in place is maintained ... care that is essential. Clement said this while, speaking at a ...
... The device, which is used for treating obstructive sleep apnea ... to be beneficial in resolving heart abnormalities, says Belgium physicians. ... that pump less effectively. ,"Not only are ... side of the heart was dilated and the heart muscle ...
... the alleged leak of question papers of the MD/MS and ... Institute of Medical Sciences (AIIMS), // has been identified ... Medical College. ,Satish Kumar (26),an MD (Paediatric) student, ... two other doctors have been taken into custody by ...
... would be targeted towards controlling the spread of three ... are haunting the Asian region. Furthermore, a 'Programme for ... Action' would be launched neat year. ,The main focus ... financial constraints that prevent the realization of the sixth ...
... announced on Thursday about its overseas expansion of acquiring ... ,This is the fourth acquisition announced by the ... takeover of Romania's Terapia for $324 million, GlaxoSmithKline Plc's ... and assets to Senetek Plc's auto-injector device by the ...
Cached Medicine News:Health News:Control And Prevention Of Three Diseases To Be Discussed: European Commission 2
... 12 L/min of Type I ultrapure water, ... Super-Q Plus System is designed to provide ... been pretreated by reverse osmosis, distillation or ... water quality which exceeds Type I ASTM/CAP/NCCLS ...
... for speed, stability and durability. Back-lighted ... modes, multiple units of measure, piece ... print, and GLP/GMP/ISO output including date ... Built-in, motor-driven internal calibration mass ...
... for speed, stability and durability. Back-lighted ... modes, multiple units of measure, piece ... print, and GLP/GMP/ISO output including date ... Touch-key calibration with external weights only ...
... Portable - Battery Powered (6 size AA ... conversion (g, ct, oz, ozt, GN, dwt, ... Counting and Percent Measure functions, Auto Print. ... Optional AC adapter may be ordered for ...
Medicine Products: